Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-084620
Filing Date
2025-06-11
Accepted
2025-06-11 06:01:09
Documents
2
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3845
2 EX-24.1 aplt-ex24_1.htm EX-24.1 12719
  Complete submission text file 0000950170-25-084620.txt   18104
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Issuer) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O APPLIED THERAPEUTICS, INC. 340 MADISON AVENUE, 19TH FLOOR NEW YORK NY 10173
Business Address
Lerner Teena (Reporting) CIK: 0001775402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38898 | Film No.: 251038699